Report Overview
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
The global GPCR-targeting Drug market size was estimated at USD 402 million in 2023 and is projected to reach USD 506.47 million by 2032, exhibiting a CAGR of 2.60% during the forecast period.
North America GPCR-targeting Drug market size was estimated at USD 109.47 million in 2023, at a CAGR of 2.23% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global GPCR-targeting Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global GPCR-targeting Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GPCR-targeting Drug market in any manner.
Global GPCR-targeting Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
PerkinElmer
Thermo Fisher Scientific
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Discoverx
Cisbio
Market Segmentation (by Type)
Reagent Test Kit
Substrate
Market Segmentation (by Application)
Oncology
Cardiovascular
Central Nervous
Other
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the GPCR-targeting Drug Market
� Overview of the regional outlook of the GPCR-targeting Drug Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GPCR-targeting Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of GPCR-targeting Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of GPCR-targeting Drug
1.2 Key Market Segments
1.2.1 GPCR-targeting Drug Segment by Type
1.2.2 GPCR-targeting Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GPCR-targeting Drug Market Overview
2.1 Global Market Overview
2.1.1 Global GPCR-targeting Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global GPCR-targeting Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GPCR-targeting Drug Market Competitive Landscape
3.1 Global GPCR-targeting Drug Sales by Manufacturers (2019-2025)
3.2 Global GPCR-targeting Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global GPCR-targeting Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers GPCR-targeting Drug Sales Sites, Area Served, Product Type
3.6 GPCR-targeting Drug Market Competitive Situation and Trends
3.6.1 GPCR-targeting Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest GPCR-targeting Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GPCR-targeting Drug Industry Chain Analysis
4.1 GPCR-targeting Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of GPCR-targeting Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GPCR-targeting Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GPCR-targeting Drug Sales Market Share by Type (2019-2025)
6.3 Global GPCR-targeting Drug Market Size Market Share by Type (2019-2025)
6.4 Global GPCR-targeting Drug Price by Type (2019-2025)
7 GPCR-targeting Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GPCR-targeting Drug Market Sales by Application (2019-2025)
7.3 Global GPCR-targeting Drug Market Size (M USD) by Application (2019-2025)
7.4 Global GPCR-targeting Drug Sales Growth Rate by Application (2019-2025)
8 GPCR-targeting Drug Market Consumption by Region
8.1 Global GPCR-targeting Drug Sales by Region
8.1.1 Global GPCR-targeting Drug Sales by Region
8.1.2 Global GPCR-targeting Drug Sales Market Share by Region
8.2 North America
8.2.1 North America GPCR-targeting Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe GPCR-targeting Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific GPCR-targeting Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America GPCR-targeting Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa GPCR-targeting Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 GPCR-targeting Drug Market Production by Region
9.1 Global Production of GPCR-targeting Drug by Region (2019-2025)
9.2 Global GPCR-targeting Drug Revenue Market Share by Region (2019-2025)
9.3 Global GPCR-targeting Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America GPCR-targeting Drug Production
9.4.1 North America GPCR-targeting Drug Production Growth Rate (2019-2025)
9.4.2 North America GPCR-targeting Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe GPCR-targeting Drug Production
9.5.1 Europe GPCR-targeting Drug Production Growth Rate (2019-2025)
9.5.2 Europe GPCR-targeting Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan GPCR-targeting Drug Production (2019-2025)
9.6.1 Japan GPCR-targeting Drug Production Growth Rate (2019-2025)
9.6.2 Japan GPCR-targeting Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China GPCR-targeting Drug Production (2019-2025)
9.7.1 China GPCR-targeting Drug Production Growth Rate (2019-2025)
9.7.2 China GPCR-targeting Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 PerkinElmer
10.1.1 PerkinElmer GPCR-targeting Drug Basic Information
10.1.2 PerkinElmer GPCR-targeting Drug Product Overview
10.1.3 PerkinElmer GPCR-targeting Drug Product Market Performance
10.1.4 PerkinElmer Business Overview
10.1.5 PerkinElmer GPCR-targeting Drug SWOT Analysis
10.1.6 PerkinElmer Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific GPCR-targeting Drug Basic Information
10.2.2 Thermo Fisher Scientific GPCR-targeting Drug Product Overview
10.2.3 Thermo Fisher Scientific GPCR-targeting Drug Product Market Performance
10.2.4 Thermo Fisher Scientific Business Overview
10.2.5 Thermo Fisher Scientific GPCR-targeting Drug SWOT Analysis
10.2.6 Thermo Fisher Scientific Recent Developments
10.3 Merck
10.3.1 Merck GPCR-targeting Drug Basic Information
10.3.2 Merck GPCR-targeting Drug Product Overview
10.3.3 Merck GPCR-targeting Drug Product Market Performance
10.3.4 Merck GPCR-targeting Drug SWOT Analysis
10.3.5 Merck Business Overview
10.3.6 Merck Recent Developments
10.4 BD Biosciences
10.4.1 BD Biosciences GPCR-targeting Drug Basic Information
10.4.2 BD Biosciences GPCR-targeting Drug Product Overview
10.4.3 BD Biosciences GPCR-targeting Drug Product Market Performance
10.4.4 BD Biosciences Business Overview
10.4.5 BD Biosciences Recent Developments
10.5 Molecular Devices
10.5.1 Molecular Devices GPCR-targeting Drug Basic Information
10.5.2 Molecular Devices GPCR-targeting Drug Product Overview
10.5.3 Molecular Devices GPCR-targeting Drug Product Market Performance
10.5.4 Molecular Devices Business Overview
10.5.5 Molecular Devices Recent Developments
10.6 Promega
10.6.1 Promega GPCR-targeting Drug Basic Information
10.6.2 Promega GPCR-targeting Drug Product Overview
10.6.3 Promega GPCR-targeting Drug Product Market Performance
10.6.4 Promega Business Overview
10.6.5 Promega Recent Developments
10.7 Qiagen
10.7.1 Qiagen GPCR-targeting Drug Basic Information
10.7.2 Qiagen GPCR-targeting Drug Product Overview
10.7.3 Qiagen GPCR-targeting Drug Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Abcam
10.8.1 Abcam GPCR-targeting Drug Basic Information
10.8.2 Abcam GPCR-targeting Drug Product Overview
10.8.3 Abcam GPCR-targeting Drug Product Market Performance
10.8.4 Abcam Business Overview
10.8.5 Abcam Recent Developments
10.9 Corning
10.9.1 Corning GPCR-targeting Drug Basic Information
10.9.2 Corning GPCR-targeting Drug Product Overview
10.9.3 Corning GPCR-targeting Drug Product Market Performance
10.9.4 Corning Business Overview
10.9.5 Corning Recent Developments
10.10 Discoverx
10.10.1 Discoverx GPCR-targeting Drug Basic Information
10.10.2 Discoverx GPCR-targeting Drug Product Overview
10.10.3 Discoverx GPCR-targeting Drug Product Market Performance
10.10.4 Discoverx Business Overview
10.10.5 Discoverx Recent Developments
10.11 Cisbio
10.11.1 Cisbio GPCR-targeting Drug Basic Information
10.11.2 Cisbio GPCR-targeting Drug Product Overview
10.11.3 Cisbio GPCR-targeting Drug Product Market Performance
10.11.4 Cisbio Business Overview
10.11.5 Cisbio Recent Developments
11 GPCR-targeting Drug Market Forecast by Region
11.1 Global GPCR-targeting Drug Market Size Forecast
11.2 Global GPCR-targeting Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe GPCR-targeting Drug Market Size Forecast by Country
11.2.3 Asia Pacific GPCR-targeting Drug Market Size Forecast by Region
11.2.4 South America GPCR-targeting Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of GPCR-targeting Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global GPCR-targeting Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of GPCR-targeting Drug by Type (2025-2032)
12.1.2 Global GPCR-targeting Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of GPCR-targeting Drug by Type (2025-2032)
12.2 Global GPCR-targeting Drug Market Forecast by Application (2025-2032)
12.2.1 Global GPCR-targeting Drug Sales (K Units) Forecast by Application
12.2.2 Global GPCR-targeting Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. GPCR-targeting Drug Market Size Comparison by Region (M USD)
Table 5. Global GPCR-targeting Drug Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global GPCR-targeting Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global GPCR-targeting Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global GPCR-targeting Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2022)
Table 10. Global Market GPCR-targeting Drug Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers GPCR-targeting Drug Sales Sites and Area Served
Table 12. Manufacturers GPCR-targeting Drug Product Type
Table 13. Global GPCR-targeting Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of GPCR-targeting Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. GPCR-targeting Drug Market Challenges
Table 22. Global GPCR-targeting Drug Sales by Type (K Units)
Table 23. Global GPCR-targeting Drug Market Size by Type (M USD)
Table 24. Global GPCR-targeting Drug Sales (K Units) by Type (2019-2025)
Table 25. Global GPCR-targeting Drug Sales Market Share by Type (2019-2025)
Table 26. Global GPCR-targeting Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global GPCR-targeting Drug Market Size Share by Type (2019-2025)
Table 28. Global GPCR-targeting Drug Price (USD/Unit) by Type (2019-2025)
Table 29. Global GPCR-targeting Drug Sales (K Units) by Application
Table 30. Global GPCR-targeting Drug Market Size by Application
Table 31. Global GPCR-targeting Drug Sales by Application (2019-2025) & (K Units)
Table 32. Global GPCR-targeting Drug Sales Market Share by Application (2019-2025)
Table 33. Global GPCR-targeting Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global GPCR-targeting Drug Market Share by Application (2019-2025)
Table 35. Global GPCR-targeting Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global GPCR-targeting Drug Sales by Region (2019-2025) & (K Units)
Table 37. Global GPCR-targeting Drug Sales Market Share by Region (2019-2025)
Table 38. North America GPCR-targeting Drug Sales by Country (2019-2025) & (K Units)
Table 39. Europe GPCR-targeting Drug Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific GPCR-targeting Drug Sales by Region (2019-2025) & (K Units)
Table 41. South America GPCR-targeting Drug Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa GPCR-targeting Drug Sales by Region (2019-2025) & (K Units)
Table 43. Global GPCR-targeting Drug Production (K Units) by Region (2019-2025)
Table 44. Global GPCR-targeting Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global GPCR-targeting Drug Revenue Market Share by Region (2019-2025)
Table 46. Global GPCR-targeting Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America GPCR-targeting Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe GPCR-targeting Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan GPCR-targeting Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China GPCR-targeting Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. PerkinElmer GPCR-targeting Drug Basic Information
Table 52. PerkinElmer GPCR-targeting Drug Product Overview
Table 53. PerkinElmer GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. PerkinElmer Business Overview
Table 55. PerkinElmer GPCR-targeting Drug SWOT Analysis
Table 56. PerkinElmer Recent Developments
Table 57. Thermo Fisher Scientific GPCR-targeting Drug Basic Information
Table 58. Thermo Fisher Scientific GPCR-targeting Drug Product Overview
Table 59. Thermo Fisher Scientific GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific GPCR-targeting Drug SWOT Analysis
Table 62. Thermo Fisher Scientific Recent Developments
Table 63. Merck GPCR-targeting Drug Basic Information
Table 64. Merck GPCR-targeting Drug Product Overview
Table 65. Merck GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Merck GPCR-targeting Drug SWOT Analysis
Table 67. Merck Business Overview
Table 68. Merck Recent Developments
Table 69. BD Biosciences GPCR-targeting Drug Basic Information
Table 70. BD Biosciences GPCR-targeting Drug Product Overview
Table 71. BD Biosciences GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. BD Biosciences Business Overview
Table 73. BD Biosciences Recent Developments
Table 74. Molecular Devices GPCR-targeting Drug Basic Information
Table 75. Molecular Devices GPCR-targeting Drug Product Overview
Table 76. Molecular Devices GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Molecular Devices Business Overview
Table 78. Molecular Devices Recent Developments
Table 79. Promega GPCR-targeting Drug Basic Information
Table 80. Promega GPCR-targeting Drug Product Overview
Table 81. Promega GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Promega Business Overview
Table 83. Promega Recent Developments
Table 84. Qiagen GPCR-targeting Drug Basic Information
Table 85. Qiagen GPCR-targeting Drug Product Overview
Table 86. Qiagen GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Qiagen Business Overview
Table 88. Qiagen Recent Developments
Table 89. Abcam GPCR-targeting Drug Basic Information
Table 90. Abcam GPCR-targeting Drug Product Overview
Table 91. Abcam GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Abcam Business Overview
Table 93. Abcam Recent Developments
Table 94. Corning GPCR-targeting Drug Basic Information
Table 95. Corning GPCR-targeting Drug Product Overview
Table 96. Corning GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Corning Business Overview
Table 98. Corning Recent Developments
Table 99. Discoverx GPCR-targeting Drug Basic Information
Table 100. Discoverx GPCR-targeting Drug Product Overview
Table 101. Discoverx GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Discoverx Business Overview
Table 103. Discoverx Recent Developments
Table 104. Cisbio GPCR-targeting Drug Basic Information
Table 105. Cisbio GPCR-targeting Drug Product Overview
Table 106. Cisbio GPCR-targeting Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Cisbio Business Overview
Table 108. Cisbio Recent Developments
Table 109. Global GPCR-targeting Drug Sales Forecast by Region (2025-2032) & (K Units)
Table 110. Global GPCR-targeting Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America GPCR-targeting Drug Sales Forecast by Country (2025-2032) & (K Units)
Table 112. North America GPCR-targeting Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe GPCR-targeting Drug Sales Forecast by Country (2025-2032) & (K Units)
Table 114. Europe GPCR-targeting Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific GPCR-targeting Drug Sales Forecast by Region (2025-2032) & (K Units)
Table 116. Asia Pacific GPCR-targeting Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America GPCR-targeting Drug Sales Forecast by Country (2025-2032) & (K Units)
Table 118. South America GPCR-targeting Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa GPCR-targeting Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa GPCR-targeting Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global GPCR-targeting Drug Sales Forecast by Type (2025-2032) & (K Units)
Table 122. Global GPCR-targeting Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global GPCR-targeting Drug Price Forecast by Type (2025-2032) & (USD/Unit)
Table 124. Global GPCR-targeting Drug Sales (K Units) Forecast by Application (2025-2032)
Table 125. Global GPCR-targeting Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of GPCR-targeting Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global GPCR-targeting Drug Market Size (M USD), 2019-2032
Figure 5. Global GPCR-targeting Drug Market Size (M USD) (2019-2032)
Figure 6. Global GPCR-targeting Drug Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. GPCR-targeting Drug Market Size by Country (M USD)
Figure 11. GPCR-targeting Drug Sales Share by Manufacturers in 2023
Figure 12. Global GPCR-targeting Drug Revenue Share by Manufacturers in 2023
Figure 13. GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market GPCR-targeting Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by GPCR-targeting Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global GPCR-targeting Drug Market Share by Type
Figure 18. Sales Market Share of GPCR-targeting Drug by Type (2019-2025)
Figure 19. Sales Market Share of GPCR-targeting Drug by Type in 2023
Figure 20. Market Size Share of GPCR-targeting Drug by Type (2019-2025)
Figure 21. Market Size Market Share of GPCR-targeting Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global GPCR-targeting Drug Market Share by Application
Figure 24. Global GPCR-targeting Drug Sales Market Share by Application (2019-2025)
Figure 25. Global GPCR-targeting Drug Sales Market Share by Application in 2023
Figure 26. Global GPCR-targeting Drug Market Share by Application (2019-2025)
Figure 27. Global GPCR-targeting Drug Market Share by Application in 2023
Figure 28. Global GPCR-targeting Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global GPCR-targeting Drug Sales Market Share by Region (2019-2025)
Figure 30. North America GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America GPCR-targeting Drug Sales Market Share by Country in 2023
Figure 32. U.S. GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada GPCR-targeting Drug Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico GPCR-targeting Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe GPCR-targeting Drug Sales Market Share by Country in 2023
Figure 37. Germany GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific GPCR-targeting Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific GPCR-targeting Drug Sales Market Share by Region in 2023
Figure 44. China GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America GPCR-targeting Drug Sales and Growth Rate (K Units)
Figure 50. South America GPCR-targeting Drug Sales Market Share by Country in 2023
Figure 51. Brazil GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa GPCR-targeting Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa GPCR-targeting Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa GPCR-targeting Drug Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global GPCR-targeting Drug Production Market Share by Region (2019-2025)
Figure 62. North America GPCR-targeting Drug Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe GPCR-targeting Drug Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan GPCR-targeting Drug Production (K Units) Growth Rate (2019-2025)
Figure 65. China GPCR-targeting Drug Production (K Units) Growth Rate (2019-2025)
Figure 66. Global GPCR-targeting Drug Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global GPCR-targeting Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global GPCR-targeting Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global GPCR-targeting Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global GPCR-targeting Drug Sales Forecast by Application (2025-2032)
Figure 71. Global GPCR-targeting Drug Market Share Forecast by Application (2025-2032)
